0 196

Cited 27 times in

The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17

Authors
 Orith Waisbourd-Zinman  ;  Hong Koh  ;  Shannon Tsai  ;  Pierre-Marie Lavrut  ;  Christine Dang  ;  Xiao Zhao  ;  Michael Pack  ;  Jeff Cave  ;  Mark Hawes  ;  Kyung A. Koo  ;  John R. Porter  ;  Rebecca G. Wells 
Citation
 HEPATOLOGY, Vol.64(3) : 880-893, 2016 
Journal Title
 HEPATOLOGY 
ISSN
 0270-9139 
Issue Date
2016
MeSH
Animals ; Benzodioxoles/toxicity* ; Bile Ducts, Extrahepatic/drug effects* ; Bile Ducts, Extrahepatic/metabolism ; Bile Ducts, Extrahepatic/pathology ; Biliary Atresia/chemically induced* ; Biliary Atresia/metabolism ; Biliary Atresia/pathology ; Cells, Cultured ; Disease Models, Animal ; Fibrosis ; Glutathione/metabolism* ; HMGB Proteins/metabolism* ; Mice, Inbred BALB C ; SOXF Transcription Factors/metabolism*
Keywords
polarity ; biliary fibrosis ; cholangiocyte ; α-smooth muscle actin
Abstract
Biliary atresia, the most common indication for pediatric liver transplantation, is a fibrotic disease of unknown etiology affecting the extrahepatic bile ducts of newborns. The recently described toxin biliatresone causes lumen obstruction in mouse cholangiocyte spheroids and represents a new model of biliary atresia. The goal of this study was to determine the cellular changes caused by biliatresone in mammalian cells that ultimately lead to biliary atresia and extrahepatic fibrosis. We treated mouse cholangiocytes in three-dimensional (3D) spheroid culture and neonatal extrahepatic duct explants with biliatresone and compounds that regulate glutathione (GSH). We examined the effects of biliatresone on SOX17 levels and determined the effects of Sox17 knockdown on cholangiocytes in 3D culture. We found that biliatresone caused disruption of cholangiocyte apical polarity and loss of monolayer integrity. Spheroids treated with biliatresone had increased permeability as shown by rhodamine efflux within 5 hours compared with untreated spheroids, which retained rhodamine for longer than 12 hours. Neonatal bile duct explants treated with the toxin showed lumen obstruction with increased subepithelial staining for α-smooth muscle actin and collagen, consistent with fibrosis. Biliatresone caused a rapid and transient decrease in GSH, which was both necessary and sufficient to mediate its effects in cholangiocyte spheroid and bile duct explant systems. It also caused a significant decrease in cholangiocyte levels of SOX17, and Sox17 knockdown in cholangiocyte spheroids mimicked the effects of biliatresone. CONCLUSION: Biliatresone decreases GSH and SOX17 in mouse cholangiocytes. In 3D cell systems, this leads to cholangiocyte monolayer damage and increased permeability; in extrahepatic bile duct explants, it leads to disruption of the extrahepatic biliary tree and subepithelial fibrosis. This mechanism may be important in understanding human biliary atresia.
Full Text
http://onlinelibrary.wiley.com/doi/10.1002/hep.28599/abstract
DOI
10.1002/hep.28599
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아과학교실) > 1. Journal Papers
Yonsei Authors
Koh, Hong(고홍) ORCID logo https://orcid.org/0000-0002-3660-7483
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/152079
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links